Clinical Trial: A Study of IBI3031 in Participants With Thyroid Eye Disease

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07622368) titled 'A Study of IBI3031 in Participants With Thyroid Eye Disease' on May 19.

Brief Summary: This is a multicenter, randomized, double-masked, placebo-controlled, single/multiple-dose-escalation trial conducted in Chinese participants with Thyroid Eye Disease (TED), aiming to evaluate the safety and tolerability of IBI3031 administered via subcutaneous or intravenous injection.

Study Start Date: May 30

Study Type: INTERVENTIONAL

Condition: Thyroid Eye Disease

Intervention: DRUG: IBI3031

subcutaneous injection or intravenous infusion.

DRUG: placebo

subcutaneous injection or intravenous infusion.

Recruitment Status: NOT_YET_RECRUIT...